Innoviva (NASDAQ: INVA) reported Q4 EPS of $0.26, $0.06 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $91.81 million versus the consensus estimate of $84.3 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.